Healthcare provider profile · identity verified

Javier Espinal, M.D

Internal Medicine · HIALEAH, FL · NPI 1023326410

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	973	297
Losartan Potassium	Losartan Potassium	620	197
Amlodipine Besylate	Amlodipine Besylate	500	158
Levothyroxine Sodium	Levothyroxine Sodium	446	136
Metformin Hcl	Metformin Hcl	358	115
Lisinopril	Lisinopril	343	109
Escitalopram Oxalate	Escitalopram Oxalate	278	53
Gabapentin	Gabapentin	246	86
Eliquis	Apixaban	229	35
Hydrochlorothiazide	Hydrochlorothiazide	222	73
Trazodone Hcl	Trazodone Hcl	220	47
Rosuvastatin Calcium	Rosuvastatin Calcium	216	87
Metoprolol Succinate	Metoprolol Succinate	214	66
Tamsulosin Hcl	Tamsulosin Hcl	213	74
Vitamin D2	Ergocalciferol (Vitamin D2)	212	61
Omeprazole	Omeprazole	206	88
Simvastatin	Simvastatin	179	59
Sertraline Hcl	Sertraline Hcl	155	26
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	148	25
Alendronate Sodium	Alendronate Sodium	141	45
Folic Acid	Folic Acid	139	24
Jardiance	Empagliflozin	137	24
Carvedilol	Carvedilol	124	42
Donepezil Hcl	Donepezil Hcl	117	43
Clopidogrel	Clopidogrel Bisulfate	116	41
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	115	37
Metoprolol Tartrate	Metoprolol Tartrate	111	35
Pantoprazole Sodium	Pantoprazole Sodium	105	43
Ezetimibe	Ezetimibe	104	40
Glipizide	Glipizide	103	38
Sildenafil Citrate	Sildenafil Citrate	100	25
Allopurinol	Allopurinol	97	30
Xarelto	Rivaroxaban	91	13
Albuterol Sulfate Hfa	Albuterol Sulfate	86	46
Montelukast Sodium	Montelukast Sodium	84	22
Meloxicam	Meloxicam	76	56
Nifedipine Er	Nifedipine	73	22
Azithromycin	Azithromycin	68	58
Ibuprofen	Ibuprofen	68	42
Memantine Hcl	Memantine Hcl	67	22
Tizanidine Hcl	Tizanidine Hcl	67	58
Farxiga	Dapagliflozin Propanediol	65	11
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	65	57
Finasteride	Finasteride	63	24
Fluticasone Propionate	Fluticasone Propionate	62	47
Alprazolam	Alprazolam	61	18
Prednisone	Prednisone	61	44
Naproxen	Naproxen	56	39
Warfarin Sodium	Warfarin Sodium	55	suppressed
Meclizine Hcl	Meclizine Hcl	50	33
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	49	12
Zolpidem Tartrate	Zolpidem Tartrate	48	suppressed
Trueplus Pen Needle	Pen Needle, Diabetic	47	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	46	41
Valsartan	Valsartan	46	16
Entresto	Sacubitril/Valsartan	45	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	45	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	44	14
Glimepiride	Glimepiride	42	15
Januvia	Sitagliptin Phosphate	42	suppressed
Latanoprost	Latanoprost	42	17
Furosemide	Furosemide	41	20
Citalopram Hbr	Citalopram Hydrobromide	40	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	40	12
Duloxetine Hcl	Duloxetine Hcl	39	12
Diclofenac Sodium	Diclofenac Sodium	37	20
Paroxetine Hcl	Paroxetine Hcl	37	suppressed
Buspirone Hcl	Buspirone Hcl	36	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	35	suppressed
Bumetanide	Bumetanide	35	suppressed
Lumigan	Bimatoprost	35	suppressed
Benzonatate	Benzonatate	34	31
Fenofibrate	Fenofibrate	34	suppressed
Hydrocortisone	Hydrocortisone	32	suppressed
Atenolol	Atenolol	31	suppressed
Famotidine	Famotidine	31	16
Brimonidine Tartrate	Brimonidine Tartrate	30	suppressed
Nitroglycerin	Nitroglycerin	30	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	28	suppressed
Chlorthalidone	Chlorthalidone	27	suppressed
Novolog Flexpen	Insulin Aspart	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Amiodarone Hcl	Amiodarone Hcl	25	suppressed
Ammonium Lactate	Ammonium Lactate	24	suppressed
Spironolactone	Spironolactone	24	suppressed
Ketoconazole	Ketoconazole	23	18
Mupirocin	Mupirocin	23	23
Janumet	Sitagliptin Phos/Metformin Hcl	22	suppressed
Lovastatin	Lovastatin	22	suppressed
Sotalol	Sotalol Hcl	22	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	21	15
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	21	suppressed
Enalapril Maleate	Enalapril Maleate	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Methylprednisolone	Methylprednisolone	21	21
Baclofen	Baclofen	20	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	19	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	19	suppressed
Brilinta	Ticagrelor	18	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	18	suppressed
Insulin Aspart Prot Mix 70-30	Insulin Aspart Prot/Insuln Asp	18	suppressed
Novolin R	Insulin Regular, Human	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	12
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Linzess	Linaclotide	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	15
Potassium Chloride	Potassium Chloride	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Acetic Acid	Acetic Acid	16	16
Dapagliflozin	Dapagliflozin Propanediol	16	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	16	suppressed
Pravastatin Sodium	Pravastatin Sodium	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	13
Trueplus Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	11
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Bicalutamide	Bicalutamide	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	14	suppressed
Temazepam	Temazepam	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Ciclopirox	Ciclopirox	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Sure Comfort	Syringe-Needle,insulin,0.5 Ml	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Ciclopirox	Ciclopirox Olamine	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Sure Comfort Pen Needle	Pen Needle, Diabetic	12	suppressed
Torsemide	Torsemide	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Eplerenone	Eplerenone	11	suppressed
Methotrexate	Methotrexate Sodium	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	11	suppressed
Repaglinide	Repaglinide	11	suppressed
Timolol Maleate	Timolol Maleate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error